You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 39 No. 11, November 1982 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL CONTRIBUTIONS
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (50)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Marker Proteins of Platelet Activation in Patients With Cerebrovascular Disease

Marc Fisher, MD; Peter H. Levine, MD; Albert L. Fullerton, MD; Ann Forsberg, MA; Celeste P. Duffy, MA; James J. Hoogasian; David A. Drachman, MD

Arch Neurol. 1982;39(11):692-695.


Abstract



• Platelet activation is assumed to occur in many patients with strokes or transient ischemic attacks (TIAs). Determination of this activity can now be measured by assaying the platelet-specific proteins, platelet factor 4 and β-thromboglobulin. These proteins are platelet specific and are released during irreversible aggregation. The plasma level of these proteins was measured in patients with strokes and TIAs and both groups had significantly greater values than healthy control subjects. These markers of platelet activation may provide further understanding of the role of platelets in the etiology, diagnosis, and treatment of cerebrovascular disease.



Author Affiliations



From the Department of Neurology (Drs Fisher, Fullerton, and Drachman), University of Massachusetts Medical School; the Division of Neurology, St Vincent Hospital (Dr Fullerton); the Blood Research Laboratory and Department of Medicine, Memorial Hospital (Dr Levine, Mss Forsberg and Duffy, and Mr Hoogasian); and the Department of Medicine, University of Massachusetts Medical Center (Dr Levine, Mss Forsberg and Duffy, and Mr Hoogasian), Worcester.


Footnotes



Accepted for publication Dec 8, 1981.

Reprint requests to Department of Neurology, University of Massachusetts Medical Center, 55 Lake Ave N, Worcester, MA 01605 (Dr Fisher).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Thrombin: Maybe not so spellbinding
del Zoppo
Neurology 2004;63:768-769.
FULL TEXT  

Course of Platelet Activation Markers After Ischemic Stroke
Marquardt et al.
Stroke 2002;33:2570-2574.
ABSTRACT | FULL TEXT  

Platelet activation: assessment and quantification
Kamath et al.
Eur Heart J 2001;22:1561-1571.
 

Altered Coagulation in Cerebral Ischemia Platelet, Thrombin, and Plasmin Activity
Fisher and Francis
Arch Neurol 1990;47:1075-1079.
ABSTRACT  

The Platelet and the Neuron: Two Cells in Focus in Migraine
Malmgren and Hasselmark
Cephalalgia 1988;8:7-24.
ABSTRACT  

Drugs and Platelet Activation in Migraine and Transient Ischemic Attacks
D'Andrea et al.
Cephalalgia 1985;5:103-108.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1982 American Medical Association. All Rights Reserved.